1
Clinical Trials associated with Allogeneic Pancreatic Islet Cells(National Institute of Diabetes & Digestive & Kidney Diseases) / No longer availableNot ApplicableIIT B-Lymphocyte Immunotherapy in Islet Transplantation: Single Subject Modification to Calcineurin-Inhibitor Based Immunosuppression for Initial Islet Graft (CIT-0501)
Type 1 diabetes is an autoimmune disease in which the insulin-producing pancreatic beta cells are destroyed, resulting in poor blood sugar control. The purpose of this study is to determine the safety and effectiveness of islet transplantation, combined with immunosuppressive medications and medications to support islet survival for treating type 1 diabetes in individuals experiencing hypoglycemia unawareness and severe hypoglycemic episodes.
100 Clinical Results associated with Allogeneic Pancreatic Islet Cells(National Institute of Diabetes & Digestive & Kidney Diseases)
100 Translational Medicine associated with Allogeneic Pancreatic Islet Cells(National Institute of Diabetes & Digestive & Kidney Diseases)
100 Patents (Medical) associated with Allogeneic Pancreatic Islet Cells(National Institute of Diabetes & Digestive & Kidney Diseases)
100 Deals associated with Allogeneic Pancreatic Islet Cells(National Institute of Diabetes & Digestive & Kidney Diseases)